| Home : February 2015 : February 24, 2015 News : The Medicines Patent Pool Signs Licensing Agreement with MSD for Paediatric Formulations of Raltegravir |
The Medicines Patent Pool Signs Licensing Agreement with MSD for Paediatric Formulations of Raltegravir |
February 24, 2015
GENEVA, February 24, 2015 /PRNewswire/ --
Company joins five other MPP patent holders in efforts to improve HIV paediatric care
The Medicines Patent Pool (MPP) announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir,...
http://www.prnewswire.com/news-releases/the-medicines-patent-pool-signs-licensing-agreement-with-msd-for-paediatric-formulations-of-raltegravir-293794221.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
